RODRIGUEZ RAUL R 4
4 · RIGEL PHARMACEUTICALS INC · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Rigel CEO Raul Rodriguez Uses 7,607 Shares for Tax Withholding
What Happened
Raul R. Rodriguez, CEO, President and Director of Rigel Pharmaceuticals (RIGL), had 7,607 shares disposed as payment for tax liability related to equity compensation. The shares were valued at $34.62 each for a total of $263,354. This was a tax-withholding disposition (code F), not an open-market sale for investment purposes.
Key Details
- Transaction date: 2026-02-10; Form filed: 2026-02-12 (filed within standard Form 4 timing).
- Price per share: $34.62; Shares disposed: 7,607; Total value: $263,354.
- Transaction code: F (payment of exercise price or tax liability — withholding of shares).
- Shares owned after the transaction: not specified in the information provided in this summary.
- No indication in the filing that this was part of a 10b5-1 plan; this appears to be routine tax withholding tied to equity compensation.
Context
Code F transactions typically reflect automatic withholding to satisfy tax obligations when an insider exercises options or vests restricted stock. These are routine administrative actions and do not necessarily indicate bullish or bearish views by the insider. Retail investors often pay more attention to purchases; withholding sales are a common outcome of exercising equity awards.
Insider Transaction Report
- Tax Payment
Common Stock
2026-02-10$34.62/sh−7,607$263,354→ 228,102 total